Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Mesenchymal Stem Cell Therapy for Virus-related Liver Cirrhosis
NCT05080465Phase 3Completed
- Sponsor
- Ukrainian Association of Biobanks
- Start
- Dec 2018
- Primary completion
- Oct 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone-marrow mesenchymal stem cells in Liver cirrhosis (LC), sponsored by Ukrainian Association of Biobanks. Started Dec 2018; status: completed.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT05080465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05080465.